Exact Mass: 429.1872918
Exact Mass Matches: 429.1872918
Found 124 metabolites which its exact mass value is equals to given mass value 429.1872918
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
C27H27NO4 (429.19399820000007)
Periglaucine D
C23H27NO7 (429.17874320000004)
A natural product found in Pericampylus glaucus.
8-Benzylcanadine
C27H27NO4 (429.19399820000007)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170
(-)-trans-2-fluorocyclohexyl-N-[p-(4-methyl-beta-D-glucopyranosyl)]phenyl-carbamate
7beta-senecioyloxy-9-(5-senecioyloxy angeloyloxy)-5,8-dehydroheliotridin-5-one|7beta-senecioyloxy-9-<5-senecioyloxy angeloyloxy>-5,8-dehydroheliotridin-5-one
C23H27NO7 (429.17874320000004)
Ala Asp Pro Gln
C17H27N5O8 (429.18595419999997)
Ala Asp Gln Pro
C17H27N5O8 (429.18595419999997)
Ala Glu Asn Pro
C17H27N5O8 (429.18595419999997)
Ala Glu Pro Asn
C17H27N5O8 (429.18595419999997)
Ala Asn Glu Pro
C17H27N5O8 (429.18595419999997)
Ala Asn Pro Glu
C17H27N5O8 (429.18595419999997)
Ala Pro Asp Gln
C17H27N5O8 (429.18595419999997)
Ala Pro Glu Asn
C17H27N5O8 (429.18595419999997)
Ala Pro Asn Glu
C17H27N5O8 (429.18595419999997)
Ala Pro Gln Asp
C17H27N5O8 (429.18595419999997)
Ala Gln Asp Pro
C17H27N5O8 (429.18595419999997)
Ala Gln Pro Asp
C17H27N5O8 (429.18595419999997)
Asp Ala Pro Gln
C17H27N5O8 (429.18595419999997)
Asp Ala Gln Pro
C17H27N5O8 (429.18595419999997)
Asp Pro Ala Gln
C17H27N5O8 (429.18595419999997)
Asp Pro Gln Ala
C17H27N5O8 (429.18595419999997)
Asp Gln Ala Pro
C17H27N5O8 (429.18595419999997)
Asp Gln Pro Ala
C17H27N5O8 (429.18595419999997)
Glu Ala Asn Pro
C17H27N5O8 (429.18595419999997)
Glu Ala Pro Asn
C17H27N5O8 (429.18595419999997)
Glu Gly Pro Gln
C17H27N5O8 (429.18595419999997)
Glu Gly Gln Pro
C17H27N5O8 (429.18595419999997)
Glu Asn Ala Pro
C17H27N5O8 (429.18595419999997)
Glu Asn Pro Ala
C17H27N5O8 (429.18595419999997)
Glu Pro Ala Asn
C17H27N5O8 (429.18595419999997)
Glu Pro Gly Gln
C17H27N5O8 (429.18595419999997)
Glu Pro Asn Ala
C17H27N5O8 (429.18595419999997)
Glu Pro Gln Gly
C17H27N5O8 (429.18595419999997)
Glu Gln Gly Pro
C17H27N5O8 (429.18595419999997)
Glu Gln Pro Gly
C17H27N5O8 (429.18595419999997)
Gly Glu Pro Gln
C17H27N5O8 (429.18595419999997)
Gly Glu Gln Pro
C17H27N5O8 (429.18595419999997)
Gly Pro Glu Gln
C17H27N5O8 (429.18595419999997)
Gly Pro Gln Glu
C17H27N5O8 (429.18595419999997)
Gly Gln Glu Pro
C17H27N5O8 (429.18595419999997)
Gly Gln Pro Glu
C17H27N5O8 (429.18595419999997)
Asn Ala Glu Pro
C17H27N5O8 (429.18595419999997)
Asn Ala Pro Glu
C17H27N5O8 (429.18595419999997)
Asn Glu Ala Pro
C17H27N5O8 (429.18595419999997)
Asn Glu Pro Ala
C17H27N5O8 (429.18595419999997)
Asn Pro Ala Glu
C17H27N5O8 (429.18595419999997)
Asn Pro Glu Ala
C17H27N5O8 (429.18595419999997)
Pro Ala Asp Gln
C17H27N5O8 (429.18595419999997)
Pro Ala Glu Asn
C17H27N5O8 (429.18595419999997)
Pro Ala Asn Glu
C17H27N5O8 (429.18595419999997)
Pro Ala Gln Asp
C17H27N5O8 (429.18595419999997)
Pro Asp Ala Gln
C17H27N5O8 (429.18595419999997)
Pro Asp Gln Ala
C17H27N5O8 (429.18595419999997)
Pro Glu Ala Asn
C17H27N5O8 (429.18595419999997)
Pro Glu Gly Gln
C17H27N5O8 (429.18595419999997)
Pro Glu Asn Ala
C17H27N5O8 (429.18595419999997)
Pro Glu Gln Gly
C17H27N5O8 (429.18595419999997)
Pro Gly Glu Gln
C17H27N5O8 (429.18595419999997)
Pro Gly Gln Glu
C17H27N5O8 (429.18595419999997)
Pro Asn Ala Glu
C17H27N5O8 (429.18595419999997)
Pro Asn Glu Ala
C17H27N5O8 (429.18595419999997)
Pro Gln Ala Asp
C17H27N5O8 (429.18595419999997)
Pro Gln Asp Ala
C17H27N5O8 (429.18595419999997)
Pro Gln Glu Gly
C17H27N5O8 (429.18595419999997)
Pro Gln Gly Glu
C17H27N5O8 (429.18595419999997)
Gln Ala Asp Pro
C17H27N5O8 (429.18595419999997)
Gln Ala Pro Asp
C17H27N5O8 (429.18595419999997)
Gln Asp Ala Pro
C17H27N5O8 (429.18595419999997)
Gln Asp Pro Ala
C17H27N5O8 (429.18595419999997)
Gln Glu Gly Pro
C17H27N5O8 (429.18595419999997)
Gln Glu Pro Gly
C17H27N5O8 (429.18595419999997)
Gln Gly Glu Pro
C17H27N5O8 (429.18595419999997)
Gln Gly Pro Glu
C17H27N5O8 (429.18595419999997)
Gln Pro Ala Asp
C17H27N5O8 (429.18595419999997)
Gln Pro Asp Ala
C17H27N5O8 (429.18595419999997)
Gln Pro Glu Gly
C17H27N5O8 (429.18595419999997)
Gln Pro Gly Glu
C17H27N5O8 (429.18595419999997)
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID
C27H27NO4 (429.19399820000007)
4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate
C21H32ClNO6 (429.19180420000004)
6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone
(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
N-[3-chloro-4-[4-[oxo-(4-propoxyphenyl)methyl]-1-piperazinyl]phenyl]propanamide
C23H28ClN3O3 (429.1819088000001)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(4-morpholinyl)phenyl]-3-imidazo[1,2-a]pyrazinamine
C24H23N5O3 (429.18008080000004)
3-[(2S,4S)-2-(4-hydroxybutoxy)-6-[4-morpholinyl(oxo)methyl]-3,4-dihydro-2H-pyran-4-yl]-1-benzopyran-4-one
C23H27NO7 (429.17874320000004)
(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
(1R,9S,10S,11S)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H25F2N3O3 (429.18638839999994)
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C20H26F3N3O4 (429.1875312000001)
(1S,9R,10R,11R)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H25F2N3O3 (429.18638839999994)
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C20H26F3N3O4 (429.1875312000001)
4F 4PP (oxalate)
C24H28FNO5 (429.19514100000004)
4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].
GNE-9278
C21H27N5O3S (429.18345120000004)
GNE-9278 is a highly selective positive allosteric modulator of NMDAR that acts at the GluN1 transmembrane domain (TMD). GNE-9278 acts on activated NMDARs to increase peak current and agonist affinity[1].
(1s,11r,13s,14s,15r,19r)-14,15-dimethoxy-20-methyl-19-(2-oxopropyl)-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-one
C23H27NO7 (429.17874320000004)